INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 222 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,958,000 | +3.5% | 318,800 | -1.3% | 0.00% | 0.0% |
| Q4 2020 | $2,859,000 | -31.3% | 322,998 | -10.0% | 0.00% | -50.0% |
| Q3 2020 | $4,164,000 | -52.1% | 359,002 | +11.3% | 0.00% | -55.6% |
| Q2 2020 | $8,690,000 | +562.3% | 322,441 | +82.8% | 0.01% | +350.0% |
| Q1 2020 | $1,312,000 | +153.3% | 176,365 | +12.4% | 0.00% | – |
| Q4 2019 | $518,000 | +475.6% | 156,899 | +255.8% | 0.00% | – |
| Q3 2019 | $90,000 | -48.0% | 44,099 | -25.1% | 0.00% | – |
| Q2 2019 | $173,000 | -25.8% | 58,857 | -5.9% | 0.00% | – |
| Q1 2019 | $233,000 | -6.8% | 62,557 | 0.0% | 0.00% | – |
| Q4 2018 | $250,000 | -28.2% | 62,557 | 0.0% | 0.00% | – |
| Q3 2018 | $348,000 | +77.6% | 62,557 | +25.4% | 0.00% | – |
| Q2 2018 | $196,000 | -16.6% | 49,899 | 0.0% | 0.00% | – |
| Q1 2018 | $235,000 | +14.1% | 49,899 | 0.0% | 0.00% | – |
| Q4 2017 | $206,000 | -34.8% | 49,899 | 0.0% | 0.00% | – |
| Q3 2017 | $316,000 | -19.2% | 49,899 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $391,000 | +18.5% | 49,899 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $330,000 | -8.8% | 49,899 | -4.2% | 0.00% | 0.0% |
| Q4 2016 | $362,000 | -25.5% | 52,099 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $486,000 | -5.8% | 52,099 | -6.6% | 0.00% | 0.0% |
| Q2 2016 | $516,000 | +2.8% | 55,799 | -3.1% | 0.00% | 0.0% |
| Q1 2016 | $502,000 | +22.1% | 57,599 | -5.9% | 0.00% | 0.0% |
| Q4 2015 | $411,000 | +16.1% | 61,199 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $354,000 | -29.1% | 61,199 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $499,000 | -8.8% | 61,199 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $547,000 | 0.0% | 61,199 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $547,000 | -9.3% | 61,199 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $603,000 | -8.9% | 61,199 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $662,000 | – | 61,199 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
| GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
| Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
| Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
| Keystone Financial Group | 109,897 | $42,751 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
| Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
| Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |